Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
BioAgeDiagnostics Strengthens Global Medical Advisory Board with Dr. Stuart M. Diamond
EIN Presswire
Board-certified longevity physician and surgeon joins BioAgeDiagnostics to accelerate the global adoption of precision longevity diagnostics.
Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)
GlobeNewswire, Inc.
Company announcement No. 35 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) Copenhagen, Denmark, July 27, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
GlobeNewswire, Inc.
Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For Full Year 2026, Company Expects Continued Growth in International Markets, Maintenance of VASCEPA’s U.S. Market Share, an Improved OPEX Profile,...
Transcritical CO2 System Market is expected to reach USD 16,650 Million by 2035, growing from USD 3,400 Million in 2026
EIN Presswire
North America recorded a 19.8% CAGR from 2026 to 2035, propelled by federal incentive programs and state mandates.
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
GlobeNewswire, Inc.
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and muscle function NMD Pharma is...
District Heating Market Set to Advance at a 1.58% CAGR Through 2035 Amid Sustainable Urban Energy Expansion
EIN Presswire
The residential segment captured roughly 57.4% of the District Heating Market in 2025, supported by mandatory connection policies in Nordic countries.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S...
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
GlobeNewswire, Inc.
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
GlobeNewswire, Inc.
STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Alpine Psychiatry Offers Comprehensive Mental Health Services Across Pennsylvania
EIN Presswire
Clinician-owned practice provides in-person and virtual psychiatric care and therapy to patients across Pennsylvania, New Jersey, and New York. KING OF PRUSSIA, PA, UNITED STATES, July 16, 2026 /EINPresswire.com/ -- Alpine Psychiatry, a...
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
GlobeNewswire, Inc.
Commercial long-term deal with a large pharmaceutical company pursuing manufacturing and commercial regulatory approvals in major markets Customer commits to AGC Biologics’ new site in Yokohama for five commercial biologics programs Highlights...
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
GlobeNewswire, Inc.
Three-year data from phase 2 trial will provide additional insights into potentially enhanced treatment effects and durability of the EVX-01-induced immune response Data will also offer insight into the vaccine’s effect also as stand-alone...
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
GlobeNewswire, Inc.
New York, USA, July 16, 2026 (GLOBE NEWSWIRE) -- Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight The Parkinson's disease clinical trial analysis report delivers important...
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
GlobeNewswire, Inc.
Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 Preclinical data for sutacimig in Factor VII deficiency (FVIID) demonstrate restoration of...
Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687
GlobeNewswire, Inc.
The Phase 2a study will evaluate AT7687 as a differentiated combination treatment approach for people living with obesity and type 2 diabetes A 13-week study of 150 randomized participants receiving either once-weekly subcutaneous AT7687 or...
Airengy and Nobian to jointly explore 2.5 GWh Compressed Air Energy Power Plant (CAPP) in Denmark
EIN Presswire
The intended compressed air power plant in Denmark adds to Airengy's previous compressed-air power plant projects in England, Romania, and Germany.
Elevara Medicines Appoints Biotech Veteran as CEO
GlobeNewswire, Inc.
Elevara Medicines Appoints Biotech Veteran as CEO Founder and former CEO of Nasdaq listed IO Biotech, Dr Mai-Britt Zocca appointed CEO Experienced chief executive with extensive operational and strategic experience in the international...
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
GlobeNewswire, Inc.
Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark, July 13, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
GlobeNewswire, Inc.
HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated partial...
South Korea and Denmark Partner on AI-Enabled Healthy Ageing and Dementia Prevention
EIN Presswire
South Korean and Danish partners develop AI-enabled prevention solutions supporting healthy ageing, independence and sustainable welfare systems.
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.